S-Nitrosylation of G protein-coupled receptor kinase 6 and Casein kinase 2 alpha modulates their kinase activity toward alpha-synuclein phosphorylation in an animal model of Parkinson's disease.
Age Factors
Animals
Casein Kinase II
/ chemistry
Disease Models, Animal
G-Protein-Coupled Receptor Kinases
/ chemistry
Gene Deletion
HEK293 Cells
Humans
Mice
Mice, Transgenic
Mutation
Nitric Oxide
/ metabolism
Nitric Oxide Synthase Type I
/ genetics
Nitroarginine
/ administration & dosage
Nitrosative Stress
Parkinson Disease
/ drug therapy
Phosphorylation
Serine
/ metabolism
alpha-Synuclein
/ chemistry
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2020
2020
Historique:
received:
23
08
2019
accepted:
06
04
2020
entrez:
29
4
2020
pubmed:
29
4
2020
medline:
21
7
2020
Statut:
epublish
Résumé
Parkinson's disease (PD) is a common neurodegenerative disorder which is mostly sporadic but familial-linked PD (FPD) cases have also been found. The first reported gene mutation that linked to PD is α-synuclein (α-syn). Studies have shown that mutations, increased expression or abnormal processing of α-syn can contribute to PD, but it is believed that multiple mechanisms are involved. One of the contributing factors is post-translational modification (PTM), such as phosphorylation of α-syn at serine 129 by G-protein-coupled receptor kinases (GRKs) and casein kinase 2α (CK2α). Another known important contributing factor to PD pathogenesis is oxidative and nitrosative stress. In this study, we found that GRK6 and CK2α can be S-nitrosylated by nitric oxide (NO) both in vitro and in vivo. S-nitrosylation of GRK6 and CK2α enhanced their kinase activity towards the phosphorylation of α-syn at S129. In an A53T α-syn transgenic mouse model of PD, we found that increased GRK6 and CK2α S-nitrosylation were observed in an age dependent manner and it was associated with an increased level of pSer129 α-syn. Treatment of A53T α-syn transgenic mice with Nω-Nitro-L-arginine (L-NNA) significantly reduced the S-nitrosylation of GRK6 and CK2α in the brain. Finally, deletion of neuronal nitric oxide synthase (nNOS) in A53T α-syn transgenic mice reduced the levels of pSer129 α-syn and α-syn in an age dependent manner. Our results provide a novel mechanism of how NO through S-nitrosylation of GRK6 and CK2α can enhance the phosphorylation of pSer129 α-syn in an animal model of PD.
Identifiants
pubmed: 32343709
doi: 10.1371/journal.pone.0232019
pii: PONE-D-19-23779
pmc: PMC7188290
doi:
Substances chimiques
SNCA protein, human
0
alpha-Synuclein
0
Nitroarginine
2149-70-4
Nitric Oxide
31C4KY9ESH
Serine
452VLY9402
NOS1 protein, human
EC 1.14.13.39
Nitric Oxide Synthase Type I
EC 1.14.13.39
Casein Kinase II
EC 2.7.11.1
G-Protein-Coupled Receptor Kinases
EC 2.7.11.16
G-protein-coupled receptor kinase 6
EC 2.7.11.16
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0232019Commentaires et corrections
Type : ErratumIn
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Proc Natl Acad Sci U S A. 1996 May 14;93(10):4565-71
pubmed: 8643444
Science. 2003 Oct 31;302(5646):841
pubmed: 14593171
Biochim Biophys Acta. 2012 Feb;1822(2):261-85
pubmed: 22024360
Neurobiol Dis. 2003 Feb;12(1):35-45
pubmed: 12609487
Mol Cell Proteomics. 2013 Dec;12(12):3543-58
pubmed: 23966418
Am J Pathol. 2000 Nov;157(5):1439-45
pubmed: 11073803
J Neurosci. 2011 Nov 16;31(46):16884-94
pubmed: 22090514
Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10810-4
pubmed: 15252205
J Neuropathol Exp Neurol. 2008 May;67(5):402-16
pubmed: 18451726
Mol Biol Cell. 2013 Jun;24(11):1649-60, S1-3
pubmed: 23576548
Biochim Biophys Acta. 2010 Nov;1802(11):935-41
pubmed: 20674742
Science. 1997 Jun 27;276(5321):2045-7
pubmed: 9197268
Nat Cell Biol. 2002 Feb;4(2):160-4
pubmed: 11813001
J Biol Chem. 2012 May 4;287(19):15345-64
pubmed: 22315227
Proc Natl Acad Sci U S A. 2009 Mar 24;106(12):4900-5
pubmed: 19273858
J Neurosci. 2010 Mar 3;30(9):3184-98
pubmed: 20203178
FEBS Lett. 2007 Oct 2;581(24):4711-7
pubmed: 17868672
Science. 2004 May 28;304(5675):1328-31
pubmed: 15105460
Cell. 1993 Dec 31;75(7):1273-86
pubmed: 7505721
Proc Natl Acad Sci U S A. 1998 May 26;95(11):6469-73
pubmed: 9600990
Nature. 1997 Aug 28;388(6645):839-40
pubmed: 9278044
Neurogenetics. 2016 Jul;17(3):145-57
pubmed: 26948950
Biochim Biophys Acta. 2009 Jul;1792(7):616-24
pubmed: 18955133
Neurobiol Dis. 2015 Dec;84:99-108
pubmed: 25796565
Mol Cell. 2010 Jul 30;39(2):184-95
pubmed: 20670888
J Neurosci. 2005 Nov 30;25(48):11165-74
pubmed: 16319316
Science. 2000 Nov 3;290(5493):985-9
pubmed: 11062131
J Biol Chem. 2000 Jan 7;275(1):390-7
pubmed: 10617630
Neuron. 2002 May 16;34(4):521-33
pubmed: 12062037
Lancet. 2015 Aug 29;386(9996):896-912
pubmed: 25904081
Front Mol Neurosci. 2014 Jun 24;7:57
pubmed: 25009465
J Neurochem. 2012 Jul;122(2):404-14
pubmed: 22537068
Parkinsonism Relat Disord. 2016 Feb;23:1-9
pubmed: 26739246
J Biol Chem. 2000 Aug 25;275(34):26515-22
pubmed: 10852916
Neuron. 2010 Jun 10;66(5):646-61
pubmed: 20547124
Proc Natl Acad Sci U S A. 2000 Jan 18;97(2):571-6
pubmed: 10639120
Proc Natl Acad Sci U S A. 2011 Aug 23;108(34):14330-5
pubmed: 21844361
Curr Opin Neurol. 2015 Aug;28(4):375-81
pubmed: 26110807
J Biol Chem. 2004 Feb 20;279(8):6834-9
pubmed: 14645218
Nitric Oxide. 2010 May 15;22(4):290-5
pubmed: 20149888
Biochem Biophys Res Commun. 2009 Jul 3;384(3):378-82
pubmed: 19410557
Sci STKE. 2001 Jun 12;2001(86):pl1
pubmed: 11752655
J Pharmacol Exp Ther. 1995 Nov;275(2):551-7
pubmed: 7473138
J Biol Chem. 2009 Jan 30;284(5):2598-602
pubmed: 19004816
J Biol Chem. 2010 Jan 22;285(4):2807-22
pubmed: 19889641
Nat Cell Biol. 2010 Nov;12(11):1094-100
pubmed: 20972425
Mov Disord. 2011 Oct;26(12):2160-8
pubmed: 21887711
Anal Biochem. 1996 Jul 1;238(2):150-8
pubmed: 8660604
J Biol Chem. 2002 Dec 13;277(50):49071-6
pubmed: 12377775
Biochim Biophys Acta. 2009 Jul;1792(7):643-50
pubmed: 19162179
J Neurosci. 2010 Oct 27;30(43):14366-70
pubmed: 20980593
Cold Spring Harb Perspect Med. 2012 Feb;2(2):a009399
pubmed: 22355802
Nat Med. 1999 Dec;5(12):1403-9
pubmed: 10581083
J Biol Chem. 2006 Oct 6;281(40):29739-52
pubmed: 16847063